Costs & Terms: Healthtech — AI Startup Funding

Where the money goes

Beyond product and team, healthtech budgets include clinical validation, study costs, regulatory consultants, quality management systems, clinical safety roles, data protection and security certifications. Investors check these are fully costed, since underestimates lead to emergency rounds on poor terms.

Staging rounds to milestones

Raising a smaller amount to reach validation, then a larger amount after approval or first contracts, usually leads to less dilution overall than raising everything upfront at an early valuation. The risk is delay: if approval slips, you must raise again before the milestone.

• Build contingency into each round for regulatory delays.
• Agree milestone definitions clearly if investment is tranched.
• Keep a bridge option in mind, such as existing investors.

Non-dilutive and partner funding

Research grants, academic partnerships and health system innovation programmes can fund studies. Life sciences or provider partners may co-fund validation. Check what rights they ask for, such as exclusivity or data ownership.

Terms to understand

Tranched investments tied to regulatory milestones are common. Check what happens if a milestone is delayed rather than failed, and how anti-dilution protections would apply in a down round caused by delays.